PubRank

European thyroid journal (Eur Thyroid J)

Journal PubWeight™ 179.18‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 2013 ETA Guideline: Management of Subclinical Hypothyroidism. 2013 1.87
2 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. 2014 1.73
3 2012 European thyroid association guidelines for metastatic medullary thyroid cancer. 2012 1.45
4 2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. 2013 1.40
5 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism. 2012 1.32
6 A Progress Report of the IFCC Committee for Standardization of Thyroid Function Tests. 2014 1.26
7 The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy. 2016 1.11
8 Thyroid Growth and Cancer. 2015 1.11
9 Thyroid hormones and the metabolic syndrome. 2013 1.10
10 Management of subclinical hypothyroidism: the thyroidologists' view. 2012 1.09
11 On the Origin of Cells and Derivation of Thyroid Cancer: C Cell Story Revisited. 2016 1.04
12 Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. 2012 0.99
13 The Dilemma of Treating Subclinical Hypothyroidism: Risk that Current Guidelines Do More Harm than Good. 2014 0.98
14 Thyroid function and obesity. 2012 0.98
15 Oxidative stress in graves' disease. 2012 0.97
16 Iodine status in europe in 2014. 2014 0.94
17 2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer. 2012 0.93
18 2013 European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors. 2013 0.92
19 Robotic surgery for thyroid disease. 2013 0.91
20 Graves' orbitopathy: imperfect treatments for a rare disease. 2013 0.90
21 Thyroid hormone actions in cartilage and bone. 2012 0.90
22 Hypothyroidism and depression. 2013 0.90
23 Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism? 2012 0.88
24 Guidance in Subclinical Hyperthyroidism and Subclinical Hypothyroidism: Are We Making Progress? 2015 0.87
25 High prevalence of papillary thyroid microcarcinoma in danish patients: a prospective study of 854 consecutive patients with a cold thyroid nodule undergoing fine-needle aspiration. 2012 0.87
26 Role of Core Needle Biopsy in the Management of Atypia/Follicular Lesion of Undetermined Significance Thyroid Nodules: Comparison with Repeat Fine-Needle Aspiration in Subcategory Nodules. 2015 0.87
27 Coexistence of thyroid-stimulating hormone-secreting pituitary adenoma and graves' hyperthyroidism. 2013 0.87
28 A placebo-controlled, blinded and randomised study on the effects of recombinant human thyrotropin on quality of life in the treatment of thyroid cancer. 2013 0.87
29 Thyroid incidentalomas: epidemiology, risk stratification with ultrasound and workup. 2014 0.86
30 Metformin and thyroid: an update. 2013 0.86
31 Ki-67 labeling index is a predictor of postoperative persistent disease and cancer growth and a prognostic indicator in papillary thyroid carcinoma. 2013 0.85
32 Basal serum thyroglobulin measured by a second-generation assay is equivalent to stimulated thyroglobulin in identifying metastases in patients with differentiated thyroid cancer with low or intermediate risk of recurrence. 2014 0.85
33 A 2016 Italian Survey about the Clinical Use of Selenium in Thyroid Disease. 2016 0.84
34 IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo. 2015 0.84
35 The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. 2015 0.84
36 Screening for congenital hypothyroidism: comparison of borderline screening cut-off points and the effect on the number of children treated with levothyroxine. 2013 0.84
37 The importance of iodine supplementation and smoking for maternal and fetal thyroid health in pregnant women. 2013 0.84
38 Low Birth Weight in Children Born to Mothers with Hyperthyroidism and High Birth Weight in Hypothyroidism, whereas Preterm Birth Is Common in Both Conditions: A Danish National Hospital Register Study. 2013 0.84
39 Thyroid hormone replacement therapy: three 'simple' questions, complex answers. 2012 0.84
40 Selenium in the Treatment of Thyroid Diseases: An Element in Search of the Relevant Indications? 2016 0.84
41 Transaxillary robotic thyroid surgery: a preliminary European experience. 2013 0.83
42 Lack of Association between Selenium Status and Disease Severity and Activity in Patients with Graves' Ophthalmopathy. 2016 0.83
43 Reply on the Letter by Stott et al. 'The Dilemma of Treating Subclinical Hypothyroidism: Risk that Current Guidelines Do More Harm than Good'. 2014 0.83
44 Environmental, lifestyle, and anthropometric risk factors for differentiated thyroid cancer in cuba: a case-control study. 2014 0.83
45 A Prospective Investigation of Graves' Disease and Selenium: Thyroid Hormones, Auto-Antibodies and Self-Rated Symptoms. 2015 0.83
46 Do Not Forget Nephrotic Syndrome as a Cause of Increased Requirement of Levothyroxine Replacement Therapy. 2015 0.82
47 Use of t4, t4 + t3, and t3 in the dutch population in the period 2005-2011. 2012 0.82
48 Thyroid tubercle of zuckerkandl is more consistently present and larger on the right: a prospective series. 2013 0.82
49 Incidence and Significance of Incidental Focal Thyroid Uptake on (18)F-FDG PET Study in a Large Patient Cohort: Retrospective Single-Centre Experience in the United Kingdom. 2015 0.82
50 Rapid bioassay for detection of thyroid-stimulating antibodies using cyclic adenosine monophosphate-gated calcium channel and aequorin. 2015 0.82
Next 50